NASDAQ · Analyst Forecast

Arcadia Biosciences, Inc. (RKDA) Stock Forecast & Price Target

$0.19 NASDAQ: RKDA Market Cap $293526

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 16, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Arcadia Biosciences, Inc. (RKDA), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Arcadia Biosciences, Inc., analysts forecast revenue falling from $7.94M in 2021 to $7.70M in 2026; the average estimate for 2026 earnings per share is −$2.42; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$0.19
Consensus targetThe average of the price targets analysts have published.$6.00
Median targetThe middle target, less affected by a single outlier.$6.00
Highest targetThe most optimistic published target.$6.00
Lowest targetThe most pessimistic published target.$6.00
Difference from priceHow far the consensus target sits from today’s price.+3057.9%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2021$7.94M$7.94M$7.94M1
2022$11.00M$11.00M$11.00M1
2023$6.25M$6.25M$6.25M1
2024$4.98M$4.98M$4.98M1
2025$5.96M$5.96M$5.96M1
2026$7.70M$7.70M$7.70M1

Earnings per share forecast

YearLowAverageHighAnalysts
2021−$23.60−$23.60−$23.601
2022−$26.40−$26.40−$26.401
2023−$9.72−$9.72−$9.721
2024−$1.10−$1.10−$1.101
2025−$2.56−$2.56−$2.561
2026−$2.42−$2.42−$2.421

Arcadia Biosciences, Inc. (RKDA) forecast — frequently asked questions

What is the analyst price target for Arcadia Biosciences, Inc.?

Analysts covering Arcadia Biosciences, Inc. (RKDA) have a consensus price target of $6.00, 3057.9% above the current price of $0.19. Published targets range from $6.00 to $6.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Arcadia Biosciences, Inc.'s earnings?

The average analyst estimate for Arcadia Biosciences, Inc. (RKDA) earnings per share in 2026 is -2.42, with individual estimates between -2.42 and -2.42.

How much revenue is Arcadia Biosciences, Inc. expected to make?

Analysts forecast Arcadia Biosciences, Inc. (RKDA) revenue of $7.70M in 2026, based on 1 published estimates.

How many analysts cover RKDA?

1 analyst contribute estimates for Arcadia Biosciences, Inc. (RKDA). Thin coverage makes an average less reliable.

Analyst forecasts for other Agricultural Inputs stocks

VYLR forecastNTR forecastCF forecastMOS forecastCTVA forecastICL forecastSMG forecastFMC forecastIPI forecastAVD stockAll Agricultural Inputs stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Basic Materials StocksLow P/E Basic Materials StocksHigh Net Margin Basic Materials StocksDividend Basic Materials StocksLow Debt Basic Materials StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.